Q4 2024 Earnings Call Transcript February 4, 2025 Amgen Inc. beats earnings expectations. Reported EPS is $5.31, expectations ...
All lines have been placed on mute to prevent any background noise. There will be a question-and-answer session at the ...
Wall Street is drifting Thursday as gains for fashion brands and cigarette makers help offset drops for Ford Motor and Qualcomm following their latest profit reports. The S&P 500 was up 0.2% in ...
AstraZeneca reports mixed results in the fourth quarter. It gains in pre-market after assuring investors that the business ...
Amgen posted Q4 sales of $9.1 billion, up 11%, surpassing forecasts. EPS beat estimates, and analysts remain optimistic about growth prospects in 2025.
In corporate news, ATS Corp (TSX: ATS) reported third-quarter revenue above estimates. ATS shares popped $2.83, or 7.4%, to $41.02.Health-care shares soared 3%, driven by a jump of nine cents, or 6.2% ...
3d
24/7 Wall St. on MSNThe Dow Jones Industrials Are Winning 2025: 4 Highest-Yielding Dogs of the Dow Are StealsWith the overall stock market very overbought, the four highest-yielding Dogs of the Dow look like outstanding ideas now.
13h
Barchart on MSNStocks Muted Before the Open With Focus on U.S. Economic Data and Amazon EarningsS&P 500 E-Mini futures are up +0.05%, andMarch Nasdaq 100 E-Mini futures are down -0.08% this morning as investors awaited a new round of U.S. economic data, remarks from Fe ...
Inc reported fourth-quarter earnings on Thursday that met analyst expectations, while revenue for the period matched consensus estimates. The fast-food restaurant operator, which owns KFC, Taco Bell, ...
Below is Validea's guru fundamental report for AMGEN INC (AMGN). Of the 22 guru strategies we follow, AMGN rates highest using our Shareholder Yield Investor model based on the published strategy ...
Below is Validea's guru fundamental report for AMGEN INC (AMGN). Of the 22 guru strategies we follow, AMGN rates highest using our Shareholder Yield Investor model based on the published strategy ...
In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against other best cancer stocks to buy. Cancer is the second leading cause of death across the globe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results